PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Nov-2020 An industry Outlook: latest regulatory challenges in Pre-filled syringe innovation SMi Group Ltd
03-Nov-2020 Epigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned Epigenomics AG
03-Nov-2020 AllianceRx Walgreens Prime named exclusive distributor for HRA Pharma Rare Diseases FDA approved prescription drugs Lysodren® and Metopirone® in the United States AllianceRx Walgreens Prime
03-Nov-2020 VFMCRP and ChemoCentryx announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan VFMCRP, ChemoCentryx
03-Nov-2020 ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors ExeVir Bio
03-Nov-2020 Food and Drug Administration Accepts BioMarin's New Drug Application for Vosoritide to Treat Children with Achondroplasia BioMarin Pharmaceutical Inc.
02-Nov-2020 Dynavax to Present at the Stifel 2020 Virtual Healthcare Conference Dynavax Technologies
02-Nov-2020 Jazz Pharmaceuticals Announces Third Quarter 2020 Financial Results Jazz Pharmaceuticals plc
02-Nov-2020 Sandoz ships first medicine in collaboration with Civica Rx to supply US hospitals Sandoz
02-Nov-2020 Halozyme Reports Third Quarter 2020 Results And Raises Full Year 2020 Guidance Halozyme Therapeutics, Inc.
02-Nov-2020 Karyopharm Announces Phase 3 SEAL Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Unresectable Dedifferentiated Liposarcoma Karyopharm Therapeutics Inc.
02-Nov-2020 Karyopharm Announces Phase 3 SEAL Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival in Patients with Unresectable Dedifferentiated Liposarcoma Karyopharm Therapeutics Inc.
02-Nov-2020 Bachem Group Webinar on Cost-efficient and Green Manufacturing of Peptides thanks to Molecular Hiving™ Technology announced  SMi Group
02-Nov-2020 Formycon Announces Virtual Annual General Meeting for December 10, 2020 Formycon AG
02-Nov-2020 Abivax announces webcast and teleconference following recent oversubscribed capital increase of  EUR 28m at market price ABIVAX
02-Nov-2020 Sosei Heptares and Aditum Bio create new company – Tempero Bio – to advance the clinical development of mGlu5 NAM program in neurological diseases Sosei Heptares and Aditum Bio
02-Nov-2020 Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients UCB
02-Nov-2020 Santhera Implements Reorganization and Secures Financing to Advance Vamorolone to Pivotal Read-out in Duchenne Muscular Dystrophy Santhera
02-Nov-2020 Xlife Sciences AG: M.M. Warburg sets price target to EUR 55.75 (news with additional features) Xlife Sciences AG
02-Nov-2020 Hearing Loss Company Acousia Therapeutics Strengthening its R&D Management Team B3C newswire